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Background: MC1R, a G-protein coupled receptor with high affinity for alpha-
melanocyte stimulating hormone (aMSH), modulates pigment production in melano-
cytes from many species and is associated with human melanoma risk. MC1R
mutations affecting human skin and hair color also have pleiotropic effects on the
immune response and analgesia. Variants affecting human pigmentation in utero alter
the congenital phenotype of both oculocutaneous albinism and congenital melano-
cytic naevi, and have a possible effect on birthweight.
Methods and Results: By in situ hybridization, RT-PCR and immunohistochemis-
try, we show that MC1R is widely expressed during human, chick and mouse
embryonic and fetal stages in many somatic tissues, particularly in the musculoskel-
etal and nervous systems, and conserved across evolution in these three amniotes. Its
dynamic pattern differs from that of TUBB3, a gene overlapping the same locus in
humans and encoding class III b-tubulin. The aMSH peptide and the transcript for
its precursor, pro-opiomelanocortin (POMC), are similarly present in numerous
extra-cutaneous tissues. MC1R genotyping of variants p.(V60M) and p.(R151C) was
undertaken for 867 healthy children from the Avon Longitudinal Study of Parent
and Children (ALSPAC) cohort, and birthweight modeled using multiple logistic
regression analysis. A significant positive association initially found between
R151C and birth weight, independent of known birth weight modifiers, was not
reproduced when combined with data from an independent genome-wide association
study of 6,459 additional members of the same cohort.
Conclusions: These data clearly show a new and hitherto unsuspected role for
MC1R in noncutaneous solid tissues before birth.
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1 | INTRODUCTION
The melanocortin-1-receptor (MC1R) gene, on human chro-
mosome 16q24.3, encodes a Gs protein-coupled receptor that
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plays a crucial role in pigmentary phenotype throughout the
vertebrate subphylum (Mountjoy, Robbins, Mortrud, &
Cone, 1992; Robbins et al., 1993). It is one of a family of
five highly-conserved membrane proteins mediating hormo-
nal responses to the hypothalamic–pituitary–adrenal axis
throughout the body. On binding, MC1R transduces signals
into melanocytes, dendritic cells with specialized organelles
called melanosomes, to augment their production of the dark
brown eumelanin that colors skin, hair, and eyes. Human
melanocytes are distributed sparsely but regularly throughout
the basal epidermis and hair follicles, from where they trans-
fer their melanosome-bound melanins to designated keratino-
cytes (Weiner et al., 2007). Melanocyte precursors, derived
from highly multipotent and migratory embryonic neural
crest cells in all vertebrates (Teillet & Le Douarin, 1970),
colonize and also synthesize pigment in noncutaneous sites
during development such as the iris, inner ear, heart and cen-
tral nervous system meninges. In the absence of light or mel-
anosome acceptors, their functions are currently not well
understood (e.g., Goldgeier, Klein, Klein-Angerer, Moell-
mann, & Nordlund, 1984; Plonka et al., 2009).
The principal high-affinity ligand of MC1R is
a-melanocyte-stimulating hormone (aMSH), a peptide pro-
duced from post-translational cleavage of pro-opiomelanocortin
(POMC), which is secreted by the anterior pituitary gland but
processed locally. Adrenocorticotropin (ACTH) is another
POMC cleavage product that can less efficiently activate
MC1R, although its principal target is adrenal MC2R (Abdel-
Malek et al., 2000; Wikberg et al., 2000). aMSH likewise
binds other, lower affinity melanocortin receptors in the central
nervous system (Wikberg et al., 2000).
In competent melanocytes, aMSH binding to MC1R trig-
gers a canonical cAMP signal transduction cascade (Newton
et al., 2005) that favors enzymatic activity within melanosomes,
leading to synthesis of eumelanin rather than the yellow-red
pigment pheomelanin from their common metabolic precursor
(Hearing & Tsukamoto, 1991). This stimulation can be antago-
nized by members of the agouti signaling protein family,
encoded by the single ASIP gene in humans, which is con-
served in both sequence and function across vertebrates and
promotes both reduction of eumelanin synthesis and concomi-
tant pheomelanin production in melanocytes (Agulleiro et al.,
2014; Suzuki et al., 1997; Yoshihara et al., 2012).
Partial loss-of-function mutations in MC1R have been
well tolerated during evolution; modulating its signaling
activity leads to a broad pigmentary palette in all vertebrate
classes examined (Andersson, 2003; Gross, Borowsky, &
Tabin, 2009; Mundy, 2005). In humans, both common (e.g.,
R151C, R160W, D294H, V92M) and rarer (D84E, R142H)
protein alterations from missense variants are associated with
reduced eumelanin and proportionately increased pheomela-
nin synthesis, which leads to lighter skin and red to blonde
hair phenotypes (Healy et al., 2001; Koppula et al., 1997).
However, many of these variants also confer an increased
risk of the pigment cell cancer, melanoma (Palmer et al.,
2000; Valverde et al., 1996). The link to oncogenesis is
thought to occur in part through variant and isoform-
dependent efficacy in stimulating the production and distri-
bution of protective eumelanin, both basally and in response
to UV light (Abdel-Malek et al., 2000), while pheomelanin
itself also increases oxidative stress in melanocytes (Mitra
et al., 2012).
Besides the cyclic AMP signaling pathway, MC1R
ligand binding also leads to cross-activation of the MAP
kinase family of effectors in both mouse and human mela-
nocytes and in human melanoma. Numerous MC1R var-
iants that affect cAMP signaling and eumelanin synthesis
do not, however, change the capacity of the proteins they
encode to activate the well-characterized effectors ERK1
(MAPK3) and ERK2 (MAPK1; Herraiz et al., 2011). Inte-
gration of multiple intracellular effector signals with that of
MC1R may therefore affect other aspects of melanocyte
physiology than the UV damage-induced tanning response.
Indeed, vertebrate integuments are already pigmented at
birth, before exposure to UV radiation. MC1R variants
modify the congenital phenotype of the rare genetic disor-
ders oculocutaneous albinism type 2 (King et al., 2003)
and large congenital melanocytic nevus (CMN; Kinsler
et al., 2012), strongly suggesting a role for MC1R in utero
at least in the presence of other mutations affecting pig-
ment synthesis or MAP kinase signaling.
The possibility of nonpigmentary effects in utero was
raised by an apparent association found between the MC1R
V92M and R151C alleles and birth weight in both CMN
patient and control cohorts (Kinsler et al., 2012). Neural crest
cells, the embryonic progenitors of melanocytes, play a key
if uncharacterized role in the induction and development of
the pituitary (Etchevers, Couly, Vincent, & Le Douarin,
1999; Ueharu et al., 2017), where both POMC and growth
hormone are produced. These observations led us to examine
how MC1R may be a modifier gene for not only rare but
common traits.
We therefore explored the hypothesis that MC1R dis-
plays pleiotropy before as well as after birth, by examining
its expression profile at different times of gestation and in
multiple orders of amniotes (bird, rodent, primate). We also
compared these findings to the expression pattern of human
TUBB3, because the first exon of TUBB3 has been annotated
to overlap the coding sequence of MC1R, hybrid trans-
criptional isoforms have been discovered in the pigment cell
lineage (Dalziel et al., 2011), and MC1R variants could
potentially have an effect via either protein product.
Ultimately, though, we confirmed that human TUBB3
expression is restricted to the central nervous system before
birth. Our data supports an evolutionarily conserved role for
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the MC1R signaling axis in the development of unexpected
tissues like muscle, cartilage, and numerous internal organs.
2 | METHODS
2.1 | In situ hybridization
Preparation and in situ hybridization of human embryonic and
fetal material was performed by the Medical Research Council
Wellcome Trust Human Developmental Biology Resource
with full ethical approval from the National Research Ethics
Service, as previously described (Sajedi et al., 2008). Mouse
embryos the morning after presumed fertilization were consid-
ered to be at embryonic day (E) 0.5, and chick embryos were
staged (Hamburger & Hamilton, 1992). These were prepared
similarly to the human embryos, with fixation in 4% buffered
paraformaldehyde in PBS at pH 7.5, paraffin embedding,
probe hybridization on 7 mm microtome sections and signal
development according to standard protocols (Moorman,
Houweling, de Boer, & Christoffels, 2001).
A 539 bp sequence within the 50UTR of the human
MC1R mRNA transcript (RefSeq: NM_002386.3) was pro-
duced by PCR using F: 50-GAGCGACGAGATGACTGG
AG-30 and R: 50-CACAGTCTGTCCTGGTCACC-30. The
PCR product was cloned into the pGEM®-T Easy vector
(Promega) and digoxigenin-incorporated riboprobes were
produced. Sense strand transcription and hybridization was
performed on parallel control sections to account for nonspe-
cific hybridization signal.
A 439 bp sequence within the Mus musculus Mc1r coding
region (RefSeq: NM_008559.2;) (Hirobe, Takeuchi, & Hotta,
2004) was produced by PCR on a genomic DNA template
with F: 50-GACCGCTACATCTCCATCTTCT-30 and the
reverse primer with an additional T7 RNA polymerase recog-
nition sequence (taatacgactcactatagggaga) added at the 50 end,
R: 50-(T7)AGGAGGAGGAAGAGGTTGAAGT-30. A 562
bp sequence within the third exon and 30 UTR of murine
Pomc (RefSeq: NM_001278582) was similarly amplified
with F: 50-TGACTGAAAACCCCCGGAAG-30 and R: 50-
(T7)CTAGAGGTCATCAGCTCGCC-30. A 318 bp sequence
within the second exon of Gallus gallus Mc1r was amplified
with F: 50-AGCCGACTCCTCGTCCACCC-30 and 50-(T7)
CACAGCACCACCTCCCGCAG-30 while a 313 bp fragment
of chicken Pomc from exon 3 was amplified with F: 50-
GTACCCGGGCAATGGGCACC-30 and R: 50-(T7)AGCC-
GACTCCTCGTCCACCC-30. Sox10 probe was synthesized
from a pBluescript vector after linearization with HindIII,
purification and T3 DNA polymerase as described (Cheng,
Cheung, Abu-Elmagd, Orme, & Scotting, 2000). Purification
and in vitro transcription of purified T7-extended PCR prod-
ucts were performed as described (Sanlaville et al., 2006).
Microphotography was undertaken with an Axioplan2
(human) or Axiozoom (animal) imaging system linked to Zen
software (Zeiss). Sequence analysis was checked to make sure
of no cross reactivity to other melanocortin receptors.
2.2 | Immunohistochemistry
Human embryonic and fetal sections were boiled with
DeclereTM (Cell Marque) to deparaffinize and rehydrate the
tissue, and unmask antigens. Slides were cooled to room
temperature and washed using Tris-buffered saline with 0.1%
Triton (TBST). Endogenous peroxidase activity within the
tissue was quenched using 3% hydrogen peroxidase. Sections
were then blocked with 10% calf serum in TBST and incu-
bated with goat anti-MC1R (N-19) polyclonal antibody
(1:100 dilution in TBST; sc-6875 Santa Cruz Biotechnol-
ogy). Sections were then washed and further incubated with
a biotinylated secondary polyclonal rabbit anti-goat (IgG)
antibody (1:500 dilution in block solution; Dako). Biotin
detection was performed using the Vectastain® ABC kit
(Vector Laboratories) and diaminobenzidine (DAB) staining.
Slides were mounted with VectaMount.
Mouse and chick embryonic and fetal sections were
deparaffinized in xylene and rehydrated in phosphate-buffered
saline with 0.1% Tween-20 (PBT) with no further antigen
unmasking. Endogenous peroxidase activity was quenched as
above. Sections were blocked with 2% calf serum in PBT and
incubated with rabbit anti-aMSH polyclonal antibody (1:100
dilution in blocking solution; NBT1–78335 Novus Biologi-
cals). After rinsing, a secondary goat anti-rabbit antibody
directly conjugated to horseradish peroxidase (111-035-144
Jackson ImmunoResearch) at 1:200 was applied and rinsed
after 1h. After DAB staining, slides were counterstained with
hematoxylin-eosin before mounting with Eukitt.
2.3 | Reverse transcriptase-PCR
Human microdissected tissues at defined stages were homog-
enized and whole RNA was extracted using the Trizol
method according to manufacturer’s recommendations (Ther-
mofisher). cDNA was synthesized using the M-MLV reverse
transcriptase kit (Promega) and assessed for the absence of
genomic DNA contamination. PCR was carried out using
standard conditions using cDNA with the following gene
specific primers: MC1R-Fwd-ACTTCTCACCAGCAGTCG-
TG, MC1R-Rev-CATTGGAGCAGACGGAGTGT. TUBB3-
Fwd- TCTACGACATCTGCTTCCGC and TUBB3-Rev-
TCGTCTTCGTACATCTCGCC.
3 | GENOTYPING ANALYSIS
3.1 | Samples
867 phenotyped ALSPAC (Avon Longitudinal Study of Par-
ent and Children http://www.bristol.ac.uk/alspac/) DNA
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samples from “Northern European/Caucasian/white” children
were assessed. Ethical approval for the study was obtained
from the ALSPAC Ethics and Law Committee and the Local
Research Ethics Committees. The entire MC1R gene was
sequenced using standard Sanger sequencing and Big Dye
Terminator v3.1 under manufacturers’ specifications (Ther-
moFisher, UK). Genotyping was carried out by sequence
trace analysis using Sequencher software (Softpedia). The
additional genotyping data for R151C was obtained from
ALSPAC upon request.
3.2 | Statistical analysis
Logistic regression modeling was used to test the hypothesis
that MC1R genotypes R151C or V92M were statistically
associated with increased birth weight in the population sam-
ples examined. The covariates added to the model were sex,
gestation (in completed weeks), maternal pre-pregnancy
weight (kg) and smoking (tobacco smoked in the last two
weeks). Only babies born at term (between 37 and 42 weeks)
were used in this study. Analysis was performed using the
SPSS statistical package (version 21).
4 | RESULTS
4.1 | Expression of MC1R during human
embryonic and early fetal development
We analyzed MC1R expression in normal human tissues
from embryos and fetuses at Carnegie stages (CS) 18 (6–7
weeks’ gestation [wg]), CS23 (8 wg), Fetal stage 1 (F1 -
early 9 wg), F3 (11 wg) and 18 wg.
In situ hybridization revealed widespread transcription of
MC1R mRNA in the skeletal system, demonstrated in the
cells, periosteum, and muscle fibers surrounding the femur
and patella, and the forelimb radius and ulna, at CS23 (Fig-
ure 1a). In addition, MC1R transcripts were observed in the
liver, pancreas, adrenal cortex, and the tubules and glomeruli
of the renal cortex at CS23, as well as the bronchial epithelia
of the lung and semicircular canals of the inner ear (Figure
1b; Supporting Information Figure S1). MC1R mRNA was
likewise detected throughout the pituitary, particularly the
anterior lobe, in the ventricular zone lining the forebrain ven-
tricles (Figure 1c), and in the neural retina and ganglionic
eminences (Supporting Information Figure S1).
Using immunohistochemistry, we confirmed expression
of MC1R protein in the chondrocytes and periosteum of the
developing femur at CS23, as well as in surrounding skeletal
muscle (Figure 1d). Positive staining was also seen in the
epiphysis of the CS23 humerus (not shown). MC1R was dis-
tributed in the basal layer of the epidermis (Figure 1e) at F3,
preceded by expression in the CS18 floor plate and ventricu-
lar zone of the brain (Figure 1f).
We then validated the presence of MC1R expression by
RT-PCR in cDNA derived from later fetal tissues. Expres-
sion was detected in a F3 (9–10 wg) muscle sample,
although not in one from 11 wg. At 18 wg, muscle, brain,
skin and kidney all transcribed MC1R, in contrast to samples
from liver and lung (Figure 1g).
During this study, it became important to be able to dis-
tinguish between human MC1R and TUBB3 transcription.
TUBB3 is known to be primarily expressed in neurons and
fetal astrocytes, where it is involved in microtubule forma-
tion (Draberova et al., 2008). Due to a “leaky” polyadenyl-
ation site between MC1R and its 30 neighbor TUBB3, it has
been shown that transcripts containing the whole of MC1R
fused to TUBB3 can also be expressed in human, although
not mouse, melanocytes (Dalziel et al., 2011; Herraiz et al.,
2015). Two distinct antibodies can recognize either endoge-
nous or chimeric TUBB3 protein in human melanoblasts and
melanocytes in vitro and in vivo (Locher et al., 2013). For
these reasons, we confirmed that in situ hybridization ref-
lected endogenous human MC1R expression by validating
with immunohistochemistry and RT-PCR. As expected from
the known function of b3-tubulin, TUBB3 mRNA expression
was only detected in the 18 wg brain sample (Figure 1h).
4.2 | Analysis of Mc1r expression in mouse
embryonic and fetal development
To compare developmental expression of MC1R with that of
other species in which additional fetal stages and tissues
could also be examined, we performed in situ hybridization
of antisense Mc1r probe to mouse sections from embryonic
day (E)11.5, E13.5, E17.5, E19.5, postnatal day 2 and adult
hairy skin. Mc1r protein expression was also examined by
immunohistochemistry at E13.5.
At E11.5, the dorsal root and cranial ganglia and the ven-
tricular zone of the central nervous system (CNS) already
expressed Mc1r. It was also transcribed at relatively lower
signal intensity throughout early skeletal muscle and meso-
nephros and many other forming tissues (Figure 2a,b). By
E13.5, expression appeared strong within liver, spinal cord
and dorsal root ganglia, and limb perichondrium and muscle
(Figure 2c). The hindbrain, pituitary gland and future cochlea
transcribed Mc1r, in addition to tongue, neck and vascular
smooth muscle (Figure 2d). Mc1r protein at this stage was
present in the heart and arterial smooth muscle, esophageal
and lung segmental bronchial epithelia (but not in main bron-
chi), and concentrated in the CNS at the floorplate and in
gray matter (Figure 2e,f). In contrast to widespread transcrip-
tion in limb, head, rib and pelvic cartilage, Mc1r was detecta-
ble in the intervertebral discs (Figure 2e) but not in the
vertebral body itself (Figure 2e,f).
Additional epithelia transcribing Mc1r in late gestation
included guard hair follicles and epidermis (Figure 2g;
446 | THOMAS ET AL.
Hirobe et al., 2004), vibrissae (Figure 2g0), and the lining of
the nasal cavity at E17.5 (Figure 2h). The nasal cartilage and
frontal bones also expressed Mc1r as well as the temporalis,
orbicularis oculi (Figure 2h) and zygomatic facial muscles.
Expression remained strong in the neurosensitive retina as
well as in CNS neurons throughout the brain, including the
forebrain and spinal cord (Figure 2h,i). The trapezius, hind-
limb muscle groups, and intercostal muscles transcribed
Mc1r (Figure 2i).
Smooth muscle layers of the stomach (E13.5) and dia-
phragm (E17.5) were positive (Figure 2c,h), and expression
also continued in the liver, lung and heart (Figure 2j) as well
as the thymus (not shown). By postnatal day (P)2, strong
transcription of Mc1r was observed in pyramidal neurons of
the hippocampus and at lower levels in motor nuclei, a sub-
ependymal layer of the cerebral cortex, and the choroid
plexus (Figure 2k). The skeletal muscle of the hypodermis
(panniculus carnosus, not shown) as well as follicular kerati-
nocytes of the inner root sheath, but not the interfollicular
epidermis, express Mc1r in adult skin (Figure 2l).
4.3 | Analysis of Mc1r expression in chicken
embryonic and fetal development
Mc1r was not detected during the first few days of develop-
ment, at stages (HH; Hamburger & Hamilton, 1992) 11, 16
FIGURE 1 HumanMC1R expression in staged late embryonic (CS18, CS23) and early fetal tissues (F1, F3). a-c, in situ hybridization; a0-c0, hybrid-
ization of adjacent sections to sense-transcribed probe (negative controls). D-F, immunohistochemistry without counterstain. a. Humerus cartilage, particu-
larly its perichondrium, skeletal muscle and skin all transcribeMC1R at CS23. b.MC1R transcripts were observed in the liver, the adrenal cortex, and the
glomeruli of the renal cortex at CS23. c. Coronal section through the ventral diencephalon at fetal stage 1 (end of 8 weeks’ gestation) demonstratingMC1R
mRNA in the ventricular zone and floorplate, the parenchyme, and throughout the pituitary gland, with strong expression in the anterior lobe. d. Protein
expression in the musculoskeletal system, including the perichondrium and cartilage of the femur and its surrounding muscles at CS23. e. Fetal skin at stage
3, approximately 10 weeks’ gestation, shows restrictedMC1R protein (arrowheads) on the apical aspect of cells in the proliferative layer of the basal epi-
dermis. No expression is observed in the dermis or in upper epidermis, although nonspecific signal is trapped in the outermost corneal layer. f. At CS18
(approximately 7 weeks’ gestation), MC1R protein is already present in neuron cell body tracts and nuclei of the hindbrain, in the ventricular zone, and par-
ticularly concentrated in the floorplate at this level. g. RT-PCR ofMC1R cDNA in fetal tissues at 18 wg, F1 (9 wg) and F3 (11 wg). h. RT-PCR of TUBB3
cDNA in 18wg tissues. Ad, adrenal gland; AL, anterior lobe; C, cartilage; CS, Carnegie stage; D, dermis; F, fetal stage; Ep, epidermis; FP, floorplate; K,
kidney; L, liver; M,muscle; Pe, perichondrium; Pit, pituitary; S, skin; VZ, ventricular (proliferative) zone of central nervous system. Bars5 100 mm
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FIGURE 2 Embryonic mouse expression ofMc1rRNA (blue) andMc1r protein expression (brown). a, b.Embryonic day of gestation E9.5, frontal
sections, antisense probe. a0. Hybridization of adjacent section to sense-transcribed probe (negative control). c. Mc1r expression is widespread at E13.5. d.
Facial, head and neck tissues at E13.5. e, f. Immunohistochemistry in sagittal and transverse section respectively at E15.5. g, g0. Hair follicles of skin (g)
and whisker vibrissae (g0) at E17.5. h. Frontal section of head, E17.5. i.Oblique section through dorsal trunk, E17.5. j. Frontal section through ventral
trunk, E17.5. k: Postnatal day 2 forebrain. l. Adult skin, hair follicles with black pigment sheath. Abbreviations: ad, adrenal gland; ao, aorta; br, bronchi;
bo, basioccipital cartilage; bs, basisphenoid; cp, choroid plexus; d, diaphragm; drg, dorsal root ganglion; fb, forebrain; fl, forelimb; fp, foreplate; h, heart;
hb, hindbrain; hp, hippocampus; IRS, inner root sheath; ivd, intervertebral disc; k, kidney; Li, liver; le, lens; Lu, lung; m, muscle; ma, mandibular artery;
Mc,Meckel’s cartilage; nc, nasal cartilage; ne, nasal epithelium; oe, oesophagus; ov, otic vesicle; p, pancreas; pit, pituitary; r, rib; ret, retina; sc, spinal cord;
scc, semi-circular canal; si, small intestine; St, stomach; t, tongue; te, temporalis muscle; v, vertebra
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and 17 (not shown). By HH24–25, weak expression app-
eared throughout the neural tube (brain and spinal cord),
somitic myotome and mesonephros (Figure 3a) as well as in
cranial ganglia, limb and pharyngeal mesenchyme (Figure
3b). More intense zones of transcription appeared in subecto-
dermal lateral plate or limb mesoderm (arrowheads, Figure
3a,b), not corresponding to specific anatomical features.
Mc1r was more widely transcribed by early fetal stage
HH29, corresponding to 6-6.5 days’ incubation. Sites
included the ectoderm and intercostal and epaxial skeletal
muscles (Figure 3c), the salivary gland, and some cephalic
muscles including oculomotor and pterygoid. Expression
was observed in the brain and cranial ganglia with compara-
tively strong expression in discrete zones of subectodermal
mesenchyme of both the beak primordium (Figure 3d,
arrows) and forelimb (Figure 3e, arrow), but little to none in
the cartilage itself.
By HH32 (approximately 7.5–8 days’ incubation), skele-
tal muscles and localized perichondrial Mc1r expression con-
tinued in both limb and trunk (Figure 3f). Areas of
mesenchyme also continued to transcribe Mc1r, in which
case the ectoderm expressed comparatively less transcript
(arrow); tracheal smooth muscle had some, but kidney (not
shown), liver and heart showed little to no Mc1r expression
at this stage.
4.4 | Ligand expression
POMC transcripts are translated into the peptide pro-
opiomelanocortin, which is enzymatically processed to yield
two hormones that are each agonists of MC1R (Suzuki et al.,
1996): the higher affinity alpha-melanocyte-stimulating hor-
mone (a-MSH), and adrenocorticotropic hormone (ACTH).
In order to establish whether Mc1r is likely to be activated
before birth by specific ligand-dependent binding, we exam-
ined the transcription of Pomc during mouse and chicken
embryogenesis by in situ hybridization.
An antisense RNA probe against murine Pomc at E11.5
showed widespread expression throughout the CNS, in
developing skeletal muscle masses, cartilage and craniofacial
mesenchyme (Figure 4a). Stronger localized expression was
seen by E13.5 in the dorsal root ganglia, spinal cord and
lung (Figure 4b) as well as liver, dermis, epaxial skeletal
muscle but also diaphragmatic and intestinal smooth muscle,
but less intensely in cartilages such as the vertebral body
(Figure 4c). In the head at the same stage (Figure 4d), Pomc
remained widely transcribed, as in the heart (cf. the mouse
heart’s Mc1r expression in Figure 2e,j). Epithelia in close
contact with overlying mesenchyme such as the salivary
glands, the nasal epithelia, the stomach and the lung were all
positive (Figure 4c,d). Pomc also showed intense expression
in areas of the tongue, nasal epithelium, pons, cerebellum
and hypothalamus. A complementary coronal section
through a chicken embryo at HH31 also showed high levels
of transcription within a subset of hypothalamic neurons and
transcription through the hindbrain (Figure 4e). The nasal
glands and epithelium, facial muscles and vibrissae, as well
as more standard-sized hair follicles of the face (Figure 4f)
expressed Pomc at E17.5 in the mouse. Within the central
nervous system, the neural retina, to a much lesser extent the
glia of the optic nerve, the hippocampus and cerebellum con-
tinued to strongly transcribe Pomc.
FIGURE 3 ChickenMc1rRNA transcription (blue) during embryonic stages. a. Oblique transverse section through trunk at HH24. b. Parasagittal
section through whole embryo, HH25. c. Oblique transverse section through dorsal trunk, HH29. d. Coronal section through nasal cartilage, presumptive
upper beak, HH29. e. Ventral forelimb, area magnified indicated on inset (hematoxylin-eosin stain), HH29. f. Parasagittal section through upper chest cav-
ity, HH32. Abbreviations: ao, aorta; br, bronchus; d, dermis; drg, dorsal root ganglia; em, epaxial muscle; ep, epidermis; es, esophagus; fb, forebrain; h,
heart; hb, hindbrain; gVII, acoustic ganglion; im, intercostal muscle; lb, forelimb bud; li, liver; lu, lung; m, muscle; md, mandible; mn, mesonephros; my,
myotome; ov, otic vesicle; r, rib; sc, spinal cord; v, vertebra
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FIGURE 4 Embryonic mouse Pomc transcription and embryonic chicken Pomc expression as relates toMc1r and/or Sox10 transcription (blue). a.
Frontal section, E11.5; strong expression in rib cartilage and intercostal and limbmuscle masses, mandibular mesenchyme, and gut. a0. Hybridization of
adjacent section to sense-transcribed probe (negative control). b. Oblique parasagittal section through upper dorsal trunk at E13.5; strong expression in cen-
tral and peripheral nervous systems and lungmesenchyme. c. Transverse section through trunk at same stage, showing widespread additional transcription
by smooth and skeletal muscle and liver. d. E13.5 head in sagittal section, showing hypothalamic, cerebellar, pontine and pituitary transcription ofPomc,
as well as in heart and tonguemuscle. e. Coronal section of an embryonic chicken at stage HH31with extremely strong transcription by hypothalamic neu-
rons in addition to expression throughout the brain. f. Mouse E17.5 coronal section through the level of the eye with strikingPomc expression in the neural
retina, facial muscles but not cartilage, and nasal glands. g. The hypothalamus, cerebellum and select hindbrain nuclei express relatively morePomc tran-
script at E17.5. h, i: Adjacent sections of chicken forelimb at HH29, hybridized respectively with probes against Pomc andMc1r. Pomc (h) is more broadly
expressed throughout connective tissues, cartilage and the dermis and intense staining is present in skeletal muscle. i.Mc1r is also expressed in muscle
masses but also regions of perichondrium and a specific zone of dermis (arrow) not anatomically distinguished. j-l: Tangential sections through wing skin
and feather follicles at HH37, with probes against (j) Pomc - asymmetric dermal expression indicated by arrows, (k)Mc1r - artifact labeled with orange
asterisk - or (l) Sox10 (melanoblasts). Abbreviations: ah, adenohypophysis; c, cartilage; cb, cerebellum; cp, choroid plexus; dia, diaphragm; drg, dorsal root
ganglon; g, gut; h, heart; hb, hindbrain; hp, hippocampus; hy, hypothalamus; lb, forelimb bud; li, liver; lu, lung; m, muscle; md, mandible; ne, nasal epithe-
lium; ng, nasal gland; on, optic nerve; pons, pontine flexure; ret, retina; sc, spinal cord; st, stomach; tg, tongue; v, vertebra; vib, vibrissa
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We compared the expression domains of Pomc to Mc1r
in the HH29 chicken forelimb (Figure 4h,i; also cf. Figure
3e). While Pomc was widely expressed, Mc1r was also
widely expressed, with lesser transcription in connective tis-
sue throwing muscle and perichondrial transcription into
higher relief. Strong expression in a region of junctional der-
mis on the proximal ventral face for Mc1r (Figure 4i, arrow)
was complementary to strong dermal transcription of Pomc
under the rest of the limb epidermis (Figure 4h). Both Pomc
and Mc1r continued to be expressed in feather follicular epi-
dermis and dermis, with an asymmetric distribution of Pomc
in the same dermal compartments seen in cross-section (Fig-
ure 4j,k). Mc1r also appears to be in feather melanoblasts at
this age, highlighted by their specific transcription of the
FIGURE 5 Immunolocalization of alpha melanocyte-stimulating hormone (aMSH) in mouse and chicken embryonic tissues. a-f: Each had an adja-
cent section counterstained but incubated without primary antibody as a negative control (a0-f0). a. Mouse E13.5 limbs showaMSH in skin, muscles and
perichondrium. b.At the same stage,aMSH in the heart. c.By E17.5 in the mouse limb,aMSH production is strong in the epidermis but also in the dermis
and all skeletal muscle, but excluded from hypertrophic cartilage. d, e. aMSH is unexpectedly produced by numerous internal organs at the same stage. f.
In addition to the skin, interdigital mesenchyme before digit separation is complete, expresses aMSH, in contrast to the digital cartilage. g.Chicken embry-
onic eye at HH29 shows strong choroidal expression of aMSH in close proximity to the blood vessels and retinal pigmented epithelium. h.At the same
stage, immunoreactivity was observed throughout the epidermis but also in discrete limb and flank subectodermal dermis regions (arrowheads), in perineu-
ral sheaths but not in dorsal root ganglia. i. aMSH is produced in distal nerves of the forelimb at HH29, in the epidermis with the exception of interdigital
skin (brackets). As in the trunk,aMSH is produced by specific domains of underlying dermal mesenchyme at the tips of the growing digits. Abbreviations:
A, adrenal; at, atrium; bv, blood vessel; c, cartilage; Ch, ocular choroid; d, dermis; drg, dorsal root ganglia; ep, epidermis; K, kidney; li, liver; m, muscle; n,
nerves; P, pancreas; RPE, retinal pigmented epithelium; Scl, sclera; SI, small intestine; ve, ventricle
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transcription factor Sox10 (Figure 4l), at the onset of the
period when the chicken fetus begins to show pigmentation
of some maturing follicles.
Immunohistochemistry against aMSH (Figure 5) showed
that most but not all embryonic sites of Pomc transcription
yielded the presence of this specific ligand in chicken or
mouse. At murine E13.5, aMSH was synthesized in limb
epidermis, muscle masses, perichondrium and cardiomyo-
cytes (Figure 5a-b). By E17.5, immunoreactivity remained
strong in limb skin and skeletal muscle (including the panni-
culus carnosus) but not in the cartilage or perichondrium
(Figure 5c). The hormone was also produced by the E17.5
liver, pancreas, intestinal epithelium, adrenal gland and kid-
ney (Figure 5d,e), as well as interdigital mesenchyme (Figure
5f). In the chicken, strong immunoreactivity was observed in
the ocular choroid plexus, between the retinal pigmented epi-
thelium and the (negative) sclera (Figure 5g), at HH29. As in
the mouse limb and paw, synthesis was excluded from
embryonic chicken cartilage at this stage in both proximal
limb and wingtip, as well as from the dorsal root ganglia.
However, aMSH immunoreactivity was observed in perineu-
ral sheaths and distal nerves; subectodermal mesenchyme in
a manner reminiscent of, but not superimposing, Mc1r tran-
scription in body wall and limb (cf. Figure 3), and to a lesser
extent in interdigital mesenchyme (Figure 5h).
4.5 | Birth weight analysis using logistic
regression modeling
In an earlier study, we found that of 270 normal children
from the English ALSPAC study (Jones et al., 2000), 42 car-
ried at least one R151C variant and 39 at least one V92M
variant of MC1R. These genotypes were independently sig-
nificantly associated with increased birth-weight (p5 0.002),
and independent of known birthweight modifiers (Kinsler
et al., 2012). We therefore genotyped 867 children from the
ALSPAC cohort for these two alleles, and confirmed a sig-
nificant positive association (p5 0.05) between the R151C
variant and birth weight in this group, again independent of
other known modifiers (Table 1). Within this larger sample,
MC1R R151C-variant newborns had a mean birthweight that
was 74 g grams heavier than other genotypes, including wild
type and other variants. However, V92M no longer showed a
significant association with birth weight (p5 0.41). When
combined with GWAS data using 6,459 additional individu-
als from the same cohort (total samples analysed 7,326), the
R151C association also was no longer significant (p5 0.40)
(Table 1). Thus, variations in MC1R genotype and, by exten-
sion, signaling activity, do not appear to correlate with birth
weight in the general English population as represented by
the ALSPAC cohort. A similar analysis was then performed
using maternal MC1R genotype at these two alleles, and
birthweight of the child. We had postulated that a connection
between maternal genotype and Vitamin D status could have
nutritional effects on growth of the fetus. However this anal-
ysis also failed to demonstrate a significant association.
5 | DISCUSSION
Our previous study led us to consider functional roles for
MC1R before birth that may affect weight at birth, and
thereby to investigate its expression in the developing
embryo. In this work, we have demonstrated evolutionary
conservation of previously-undescribed Mc1r and MC1R
expression domains, particularly in specific compartments of
the prenatal skin and skeletal musculature, in three amniote
species including humans. In addition, the widespread tran-
scription of Pomc we document for the first time in the
developing tissues of both avian and murine embryos, sup-
ports an evolutionarily conserved role for Mc1r in regulating
growth of multiple organ systems, including those potentially
affecting weight at birth. Investigation of potential correla-
tions between two variant MC1R genotypes and increased
birth weight in human infants did not allow us to further sup-
port the hypothesis that these alleles had a measurable effect
on this specific phenotype for the general population. Intrigu-
ingly, many years ago, strong correlation between light hair
and freckling, traits known to be influenced by MC1R geno-
type, and “body build” (an early type of BMI relating height
to weight) had already been noted (Brues, 1950). Model
TABLE 1 Association of MC1R genotype with birth weight
Predictor
Effect size
(grams) p value
Sex 132.2 <1 3 10216
Gestation 118.8 <1 3 10216
Mother’s weight (kg) 10.1 <1 3 10216
Smoking 287.8 5.1 3 1026
R151C with above factorsa 73.6 0.05
V92M with above factorsa 33.9 0.41
R151C with above factorsb 210.7 0.40
MC1R R151C is positively associated with heavier birth weight (p< 0.05)
using in-house Sanger sequenced genotyping data obtained from 867 subjects,
but this association disappears (p5 0.40) when combined with ALSPAC
GWAS data from an additional 6,459 individuals (n5 7,326 normal births).
V92M has no association with birth weight using in-house genotyping data
(GWAS data unavailable for V92M). Covariates known to affect birth weight
(infant sex, total gestation in weeks, pre-pregnancy weight in kilograms and
level of tobacco smoke) were added to the model.
aData available from 867 initial in-house samples.
bData from 7,326 individuals (867 from in-house genotyping plus 6,459
ALSPAC GWAS data).
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systems may better lend themselves to future investigations
of whether body mass is influenced by Mc1r activity in
humans or other animals.
Nonetheless, data presented here clearly show that
although amniote embryos are pigmented at birth, the
aMSH-Mc1r signaling axis plays roles well beyond the pro-
motion of postnatal melanogenesis in the three species exam-
ined here. In humans, pleiotropic effects of MC1R are
already known in post-natal life. UV stimulation of aMSH
production in the epidermis leads to paracrine MC1R binding
and activation in interfollicular melanocytes to promote the
synthesis of eumelanin and, ultimately, a tanning response in
vivo, but also to their population expansion in vitro (Abdel-
Malek et al., 2000; Valverde, Healy, Jackson, Rees, &
Thody, 1995). Women with two variant MC1R alleles show
greater pain relief in response to the j-opioid pentazocine;
Mc1r mediates j-opioid analgesia in mice as well (Mogil
et al., 2003). Later work demonstrated overall decreased
nociception in both humans and mice bearing functionally
variant MC1R/Mc1r alleles that decrease eumelanin synthesis
(so-called “red hair” alleles), implying that endogenous acti-
vation of MC1R may counteract m-opioid-mediated analgesia
and confer greater basal pain sensitivity to noncarriers of
both sexes (Mogil et al., 2005). MC1R transfected into
immortalized human embryonic kidney cells leads to an
apparent agonist-independent increase in cAMP levels (San-
chez-Mas, Hahmann, Gerritsen, Garcia-Borron, & Jimenez-
Cervantes, 2004). We have found that Pomc is normally
transcribed in the fetal mouse kidney and that human embry-
onic kidney strongly expresses MC1R, supporting a prepon-
derant role for ligand-dependent stimulation in vivo, be it
autocrine, paracrine or endocrine.
Human primary chondrocytes isolated from osteoarthritic
adult knees express aMSH-responsive MC1R, and signal
through the cAMP pathway to induce the synthesis of colla-
gens as well as some MMP degradation enzymes (Grässel
et al., 2009). A chondrosarcoma cell line also expresses
MC1R and reduces levels of post-inflammatory MMP13
transcription in response to aMSH, while healthy primary
chondrocytes do not. Our observation of normal expression
of Mc1r in the perichondrium in embryonic chick, mouse
and human cartilage, and of the protein within fetal chondro-
cytes, supports the hypothesis that MC1R activity normally
promotes growth and matrix remodeling of developing carti-
lage. More intriguingly yet, we observed strong MC1R
receptor expression in the developing human heart, kidney,
adrenal gland, liver, pancreas and lung.
In mice, where inter-follicular melanocytes rapidly disap-
pear after birth from most sites and postnatal pigmentation is
thereafter restricted to a self-renewing population within hair
follicles, Mc1r stimulation by aMSH favors the terminal dif-
ferentiation of as yet unpigmented melanoblasts (Hirobe,
1992). We have now shown that Mc1r is widely expressed
in the pre- and perinatal epidermis but restricted by P2 to the
follicular bulb and sheath within which melanoblasts are
embedded, suggesting that both epidermal components
develop in synchronized but cell-specific manners in
response to hormonal stimulation. In addition, Mc1r-null
mice are less resistant to experimentally induced oxidative
stress and inflammation, leading to dermal fibrosis and colla-
gen synthesis or the aggravation of colitis (B€ohm & Stege-
mann, 2014). In humans, the R163Q allele of MC1R, which
leads to reduced cAMP signaling upon aMSH binding, is
also strongly associated with susceptibility to hypertrophic
scarring (Sood et al., 2015).
Finally, in the developing chicken, we have shown that
feather germ keratinocytes express Mc1r by mid-gestation,
when Sox101 melanoblasts are present within the sheath
and interfollicular epidermis. Sox10 is a transcription factor
that is expressed by multipotent neural crest cells, repressed
temporarily upon their colonization of the epidermal
annexes, and re-expressed by transiently amplifying and ter-
minally differentiated melanocytes (Osawa et al., 2005). The
Pomc transcript is expressed asymmetrically in cross-section
of the dermal pulp. Interestingly, the Asip antagonist is also
asymmetrically translated later, within the postnatal dermal
pulp compartment, facing, and likely regulating the color of,
forming feather barbs (Yoshihara et al., 2012).
In conclusion, we have identified MC1R expression in a
range of unreported tissues in the developing human, chick
and mouse embryo and fetus. Expression of both ligand and
receptor in multiple sites of subepithelial mesenchyme and in
many similar tissues and organs suggest that MC1R has
widespread unknown functions in fetal growth and differen-
tiation, evolutionarily conserved across species.
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